Pazopanib
ATC Code
L01EX03
Pazopanib
Definition
A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.
Also known as Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, GW786034, PAZOPANIB — per NCIT
Also identified as
- ATC L01EX03 per RXNORM
- NCIT NCIT:C74547 per NCIT
- SCTID 443763005 per RXNORM
- SCTID 443764004 per RXNORM
- UNII 7RN5DR86CK per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Renal cell carcinoma | may treat | MEDRT · Public domain (U.S. Government work) |